Skip to content

Effectiveness of Iranian Medicine Product: Tamarrindus Indica L. Syrup (Somalax) on Patients with Acne.

Effectiveness of Iranian Medicine Product: Tamarrindus Indica L. Syrup (Somalax) Compared to Placebo on Patients with Mild to Moderate Acne: A Triple_Blind Randomized Clinical Trial

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20191103045318N1
Enrollment
110
Registered
2020-01-13
Start date
2019-11-22
Completion date
Unknown
Last updated
2020-02-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acne. Acne, unspecified

Interventions

Intervention 1: Intervention group:Iranian medicine product, Somalax syrup (83.3 mg per hl, yellow herb 41.7 mg, jujube 8.20 mg, floss 8.20 mg, red sugar 8.50 mg, Indian spice 5.62 mg) Grams, vinegar

Sponsors

Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Age over 18 years Mild to moderate acne on the face Lack of a history of systemic disease when the patient has to take systemic medication No use of inducing or reducing acne medications in the last 2 weeks No facial surgery in the last month No pregnancy and no breast feeding Willingness to participate in the study

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Acne severity index. Timepoint: At baseline (before intervention) and at 6, 12, and 16 weeks after drug administration. Method of measurement: The lesion is counted by the researcher and placed in the ASI formula.

Secondary

MeasureTime frame
Quality of life score. Timepoint: At baseline (before intervention) and 16 weeks after drug administration. Method of measurement: DLQI Quality of Life Questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactRazieh Kasraei

Tehran University of Medical Sciences

dr.kasraei@yahoo.com+98 21 8809 9869

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026